FDA Inspection
Patheon Biologics B.V.Patheon Biologics B.V. – FDA Inspection, Feb 13, 2018
Record Details
This FDA Inspection record concerns Patheon Biologics B.V., with an inspection on February 13, 2018, issued by the Office of Inspections and Investigations, covering human drugs.
- People
- Kathleen R. Jones (Company Rep)
- Maria J. Lopez- Barragan (Issuing Officer)
- Wayne E. Seifert (Senior Regulatory Specialist)
View Company Profile
ID · 2976775d-7531-4d24-a17c-a632cc0714a8
Inspection Facts
- Inspection number
- 1051335
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Patheon Biologics B.V.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 28, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 9, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 14, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 9, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Patheon Biologics B.V.
- FDA Inspection 1204968 - 2023-03-28
- FDA Inspection 1206906 - 2021-11-09
- FDA Inspection 903359 - 2014-11-14
- FDA Inspection 678752 - 2010-07-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.